{"entity":{"type":"insider","cik":"0001473273","url":"/insider/0001473273","json_url":"/insider/0001473273.json","name":"NewcoGen Long Reign Holding LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":3,"first":"2009-10-05","last":"2014-12-05","span_basis":"filed_date"},"name_variants":[{"name":"NewcoGen Long Reign Holding LLC","source":"filing","n_filings":3,"first_seen":"2009-10-05","last_seen":"2014-12-05"}],"transactions":[{"id":6185372,"accession":"0001181431-14-038229","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-14-038229","line_url":"/filing/0001181431-14-038229","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"NewcoGen Long Reign Holding LLC; AFEYAN NOUBAR; Flagship Ventures Management, Inc.; NewcoGen Group, Inc.; KANIA EDWIN M JR","owner_display_name":"NewcoGen Long Reign Holding LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":260.0,"shares_display":"260","price_per_share":0.46,"price_display":"0.46","price_state":"stated","total_value":119.6,"total_display":"119.60","total_whole":"120","shares_owned_after":98570.0,"shares_owned_after_display":"98,570","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-03","filed_date":"2014-12-05","scope":"insider","n_lines":5},{"id":9160361,"accession":"0001181431-11-009580","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001181431-11-009580","line_url":"/filing/0001181431-11-009580","is_derivative":false,"issuer_cik":"0001097546","issuer_name":"BG Medicine, Inc.","issuer_ticker":"BGMD","issuer_name_source":null,"issuer_url":"/issuer/0001097546","owner_cik":null,"owner_name":"NewcoGen PE LLC; KANIA EDWIN M JR; Flagship Ventures Management, Inc.; AFEYAN NOUBAR; NEWCOGEN EQUITY INVESTORS LLC; NewcoGen Group, Inc.; ST NewcoGen LLC; NewcoGen Elan LLC; NEWCOGEN GROUP LLC; NewcoGen Long Reign Holding LLC","owner_display_name":"NewcoGen PE LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1142857.0,"shares_display":"1,142,857","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":7999999.0,"total_display":"7,999,999.00","total_whole":"7,999,999","shares_owned_after":714286.0,"shares_owned_after_display":"714,286","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-09","filed_date":"2011-02-11","scope":"insider","n_lines":9},{"id":9241371,"accession":"0001179110-09-014191","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-09-014191","line_url":"/filing/0001179110-09-014191#line-1","is_derivative":false,"issuer_cik":"0001473273","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001473273","owner_cik":null,"owner_name":"AFEYAN NOUBAR; NewcoGen Long Reign Holding LLC","owner_display_name":"AFEYAN NOUBAR","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":242931.0,"shares_display":"242,931","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":12192640.0,"shares_owned_after_display":"12,192,640","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-18","filed_date":"2009-10-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001407038","name":"BG Medicine, Inc.","url":"/issuer/0001407038","role":"Ten percent owner","n_filings":2,"first_seen":"2011-02-11","last_seen":"2014-12-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001274563","name":"HELICOS BIOSCIENCES CORP","url":"/issuer/0001274563","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2009-10-05","last_seen":"2009-10-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001473273","retrieved_at":"2026-08-22T09:55:54+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}